Donate to this fund
New breakthroughs have allowed researchers to now target disease causing mutations on the genetic level. Our lab focuses on the targeted reactivation of genes implicated in Rett Syndrome and focuses on translating these findings in clinically-relevant ways. With your generosity we can continue to advance our efforts to bring research and potential interventions closer to clinical trials.
Managing Executive Director of Development